Study of NS-9 in Patients With Liver Metastases

Summary

This study is to investigate the safety of NS-9 and to see how well it is tolerated in patients with cancer that has metastasized (spread) to the liver from another primary tumor. NS-9 is a drug developed to go to the liver to cause cell death specifically in tumor cells. This study is also set up to determine the best dose to use.

Timeline

Start

2002-09

Primary completion

—

Completion

—

Drugs

Indications